How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin’s lymphoma patients?-Reference-Cited by-同舟云学术

How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin’s lymphoma patients?

Published:1999-10 Issue:10 Volume:10 Page:1141-1143
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Coiffier B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/10/1141/19477025/10-10-1141.pdf

Reference21 articles.

1. Prognostic factors in aggressive malignant lymphomas;Coiffier;Description and validation of a prognostic index that could identify patients requiring a more intensive therapy. J Clin Oncol,1991

2. Residual abdominal masses in aggressive non-Hodgkin’s lymphoma after combination chemotherapy: Significance and management;Surbone;J Clin Oncol,1988

3. Report of an International Workshop to standardize response criteria for non-Hodgkin’s lymphomas;Cheson;J Clin Oncol,1999

4. Monitoring bulky mediastinal disease with gallium-67, CT scan and magnetic resonance imaging in Hodgkin’s disease and high-grade non-Hodgkin’s lymphoma;Zinzani;Leuk Lymph,1996

5. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma;Hill;J Clin Oncol,1993

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02;Clinical & Experimental Metastasis;2019-09-25

2. Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma;Chinese Journal of Cancer;2015-06-10

3. Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma;Nuclear Medicine and Molecular Imaging;2010-02-26

4. The role of FDG PET in the management of lymphoma: what is the evidence base?;Nuclear Medicine Communications;2007-05

5. Revised Response Criteria for Malignant Lymphoma;Journal of Clinical Oncology;2007-02-10